When.com Web Search

  1. Ads

    related to: form 10 k405 2020

Search results

  1. Results From The WOW.Com Content Network
  2. Form 10-K405 - Wikipedia

    en.wikipedia.org/wiki/Form_10-K405

    Form 10-K405 is an SEC filing to the US Securities and Exchange Commission (SEC) that indicates that an officer or director of a public company failed to file a Form 4 (or related Form 3 or Form 5) on time, in violation of Section 16 - meaning that they did not disclose their insider trading activities within the required time period.

  3. Category:SEC filings - Wikipedia

    en.wikipedia.org/wiki/Category:SEC_filings

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more

  4. Form 10-K - Wikipedia

    en.wikipedia.org/wiki/Form_10-K

    A Form 10-K is an annual report required by the U.S. Securities and Exchange Commission (SEC), that gives a comprehensive summary of a company's financial performance. . Although similarly named, the annual report on Form 10-K is distinct from the often glossy "annual report to shareholders", which a company must send to its shareholders when it holds an annual meeting to elect directors ...

  5. SEC filing - Wikipedia

    en.wikipedia.org/wiki/SEC_filing

    Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT (Amendment) NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB NT 10-Q/A Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB (Amendment) NT 11-K

  6. W. R. Grace and Company - Wikipedia

    en.wikipedia.org/wiki/W._R._Grace_and_Company

    [10] In July 2016, the company acquired a catalysts business from BASF. [11] In June 2021, the company acquired a unit from Albemarle Corporation. [12] In September 2021, Standard Industries acquired the company. [13] [14] [15]

  7. Journal pulls scientific paper that popularized ... - AOL

    www.aol.com/journal-pulls-scientific-paper...

    The paper, published in 2020 in the International Journal of Antimicrobial Agents, originally claimed that treatments with hydroxychloroquine, an anti-malaria drug, reduced virus levels in COVID ...